A simple blood test may soon be able to diagnose patients with two common forms of dementia – Alzheimer’s disease and frontotemporal dementia – and tell the two apart.

Those who purchase an annual UCSF parking permit can expect the cost of that permit to increase substantially beginning July 1, mainly given a recent California Supreme Court ruling.

A blood test that may eventually be done in a doctor’s office can swiftly reveal if a patient with memory issues has Alzheimer’s disease or mild cognitive impairment and can also distinguish both conditions from frontotemporal dementia.

As concerns about the coronavirus outbreak begin hitting closer to home, UC San Francisco infectious disease experts are providing the latest updates on how to protect yourself, when to seek medical attention, and who is being tested.

Administering stem cell or enzyme therapy in utero may be a path to alleviating some congenital diseases that often result in losing a pregnancy, according to a new study in mice by UCSF researchers. They showed that stem cells can enter the fetal brain during prenatal development and make up for cells that fail to make an essential protein.